Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a New Istaroxime Patent
October 25, 2021 07:30 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree Hosting Key Opinion Leader Webinar on Istaroxime for the Treatment of Acute Heart Failure and the Upcoming Data in Early Cardiogenic Shock
October 14, 2021 07:30 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study
October 12, 2021 07:30 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 16, 2021 07:30 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions...
Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates
August 05, 2021 16:01 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree Appoints Randall White, Ph.D., as Vice President, Clinical Program Management
August 02, 2021 08:00 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree to Present at Access to Giving Virtual Investor Conference
July 08, 2021 07:30 ET
|
Windtree Therapeutics
WARRINGTON, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree to Present at the Ladenburg Thalmann 2021 Healthcare Conference (Virtual)
July 07, 2021 07:30 ET
|
Windtree Therapeutics
WARRINGTON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
August 13, 2020 19:36 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical...
Windtree Therapeutics to Present at the Fall Investor Summit
September 10, 2019 08:00 ET
|
Windtree Therapeutics
WARRINGTON, Pa., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical...